[An analysis of 117 cases of patients who died from tumor recurrence or from the progression of ovarian malignancies].
Out of 403 patients with ovarian with malignancies during 1978 to, 1985, 117 (29.0%) died from the progression of a non-curative cancer (56 cases, 47.9%) or from a cancer recurrence (61 cases, 52.1%). The mean survival rate 117 cases was 13.4 months, of which 103 (88.0%) cases concerned patients who died within 2 years and 114 (97.4%) who died within 3 years. A histological analysis revealed that patients with a serous or an endometrial cancer had a longer survival rate than others. Among 61 recurrent cases, 59 (96.7%) fell into recurrence within 2 years. Regarding the relationship between a recurrent of cancer and its prognosis, patients with a recurrence of an ascitic or a metastatic disease had a poorer prognosis than patients with a pelvic or an abdominal mass. An aggressive operation, such as a resection of a recurrent tumor, even if small in volume, led to a better prognostic result than no therapy.
Dept. of Obstet. & Gynec., School of Med., Nagoya Univ.
T
T
Kano
K
K
Sakakibara
N
N
Kamiya
K
K
Mizuno
T
T
Miyazaki
M
M
Ohta
Y
Y
Tomoda
D005260:Female; D006801:Humans; D007564:Japan; D009362:Neoplasm Metastasis / Q000401:mortality; D009364:Neoplasm Recurrence, Local / Q000401:mortality; D010051:Ovarian Neoplasms / Q000401:mortality* / Q000473:pathology